The daily recommended dose of CELEBREX capsules in patients with moderate hepatic impairment (Child-Pugh Class B)should be reduced by 50%. The use of CELEBREX in patients with severe hepatic impairment is not recommended [see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY]. Renal Impairment CELE...
The daily recommended dose of CELEBREX capsules in patients with moderate hepatic impairment (Child-Pugh Class B)should be reduced by 50%. The use of CELEBREX in patients with severe hepatic impairment is not recommended [see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY]. Renal Impairment CELE...
The daily recommended dose of CELEBREX capsules in patients with moderate hepatic impairment (Child-Pugh Class B)should be reduced by 50%. The use of CELEBREX in patients with severe hepatic impairment is not recommended [see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY]. Renal Impairment CELE...
The usual recommended dose for the relief of the symptoms of osteoarthritis is 7.5 mg once per day. In adults, the maximum dose is 15 mg. It starts to relieve pain about 30 to 60 minutes after intake. Side Effects And Precautions Of Meloxicam Commonside effectsmay include: drowsiness; upset...
收藏人数: 0 评论次数: 0 文档热度: 文档分类: 待分类 文档标签: celebrex2002proposal 系统标签: celebrexproposalpfizerpharmaciaconsultechcardiorenal CELEBREX2002 STRATEGIESAND COMMUNICATIONPLANS CELEBREX2002 STRATEGIESAND COMMUNICATIONPLANS Nov.2001 CONSULTECHADVERTISING AnExclusiveAffiliateofMedicusGroupInternationalin...
The daily recommended dose of CELEBREX capsules in patients with moderate hepatic impairment (Child-Pugh Class B)should be reduced by 50%. The use of CELEBREX in patients with severe hepatic impairment is not recommended [see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY]. Renal Impairment CELE...
The daily recommended dose of CELEBREX capsules in patients with moderate hepatic impairment (Child-Pugh Class B)should be reduced by 50%. The use of CELEBREX in patients with severe hepatic impairment is not recommended [see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY]. Renal Impairment CELE...
The daily recommended dose of CELEBREX capsules in patients with moderate hepatic impairment (Child-Pugh Class B)should be reduced by 50%. The use of CELEBREX in patients with severe hepatic impairment is not recommended [see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY]. Renal Impairment CELE...
The daily recommended dose of CELEBREX capsules in patients with moderate hepatic impairment (Child-Pugh Class B)should be reduced by 50%. The use of CELEBREX in patients with severe hepatic impairment is not recommended [see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY]. Renal Impairment CELE...
The daily recommended dose of CELEBREX capsules in patients with moderate hepatic impairment (Child-Pugh Class B)should be reduced by 50%. The use of CELEBREX in patients with severe hepatic impairment is not recommended [see DOSAGE AND ADMINISTRATION and CLINICAL PHARMACOLOGY]. Renal Impairment CELE...